诺华的“刺刀”出慢了,IgA肾病市场急速变脸

健识局
Sep 12

谁能想到,市场在三个月内就变天了。2025年6月之前,国内IgA肾病治疗药物十分紧俏,唯一治疗特效药“耐赋康”一度脱销。然而最近几个月,市面上相关治疗药物突然井喷。9月10日,诺华宣布一款老品种“盐酸伊普可泮胶囊”获批了IgA肾病的新适应症,成为国内第三款治疗IgA肾病的创新药;在此之前的8月20日,诺华的创新药阿曲生坦获批,用于降低IgA肾病成人患者的蛋白尿水平。这相当于,诺华拿出两款药来,直接...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10